Evidence map›Paper›PMID 38883836›Full record

ArticleiScience2024

Lung tumor discrimination by deep neural network model CanDo via DNA methylation in bronchial lavage.

Zezhong Yu, Jieyi Li, Yi Deng, Chun Li, Maosong Ye, Yong Zhang, Yuqing Huang, Xintao Wang, Xiaokai Zhao, Jie Liu and 13 more

Abstract read
In one paragraph

Article in iScience, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Zezhong YuDepartment of Respiratory Medicine, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
Jieyi LiJiaxing Key Laboratory of Precision Medicine and Companion Diagnostics, Jiaxing Yunying Medical Inspection Co., Ltd., Jiaxing 314033, China.
Yi DengDepartment of Respiratory Medicine, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
Chun LiDepartment of Respiratory Medicine, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
Maosong YeDepartment of Respiratory Medicine, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
Yong ZhangDepartment of Respiratory Medicine, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
Yuqing HuangDepartment of R&D, Zhejiang Yunying Medical Technology Co., Ltd., Jiaxing 314006, China.
Xintao WangJiaxing Key Laboratory of Precision Medicine and Companion Diagnostics, Jiaxing Yunying Medical Inspection Co., Ltd., Jiaxing 314033, China.
Xiaokai ZhaoJiaxing Key Laboratory of Precision Medicine and Companion Diagnostics, Jiaxing Yunying Medical Inspection Co., Ltd., Jiaxing 314033, China.
Jie LiuDepartment of Respiratory Medicine, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
Zilong LiuDepartment of Respiratory Medicine, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
Xia YinDepartment of Respiratory Medicine, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
Lijiang MeiDepartment of Respiratory Medicine, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
Yingyong HouDepartment of Pathology Medicine, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
Qin HuDepartment of Respiratory Medicine, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
Yao HuangDepartment of Pulmonary, Taikang Xianlin Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing 210046, China.
Rongping WangDepartment of Pulmonary, Taikang Xianlin Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing 210046, China.
Huiyu FuDepartment of R&D, Zhejiang Yunying Medical Technology Co., Ltd., Jiaxing 314006, China.
Rumeng QiuDepartment of R&D, Zhejiang Yunying Medical Technology Co., Ltd., Jiaxing 314006, China.
Jiahuan XuDepartment of R&D, Zhejiang Yunying Medical Technology Co., Ltd., Jiaxing 314006, China.
Ziying GongJiaxing Key Laboratory of Precision Medicine and Companion Diagnostics, Jiaxing Yunying Medical Inspection Co., Ltd., Jiaxing 314033, China.
Daoyun ZhangJiaxing Key Laboratory of Precision Medicine and Companion Diagnostics, Jiaxing Yunying Medical Inspection Co., Ltd., Jiaxing 314033, China.
Xin ZhangDepartment of Respiratory Medicine, Zhongshan Hospital, Fudan University, Shanghai 200032, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bronchoscopic-assisted discrimination of lung tumors presents challenges, especially in cases with contraindications or inaccessible lesions. Through meta-analysis and validation using the HumanMethylation450 database, this study identified methylation markers for molecular discrimination in lung tumors and designed a sequencing panel. DNA samples from 118 bronchial washing fluid (BWF) specimens underwent enrichment via multiplex PCR before targeted methylation sequencing. The Recursive Feature Elimination Cross-Validation and deep neural network algorithm established the CanDo classification model, which incorporated 11 methylation features (including 8 specific to the

Indexed as

CellComputing methodologyDisease

Identifiers

PMID38883836
PMCPMC11176796

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.